Control of rat C6 glioma cell proliferation: uncoupling of the inhibitory effects of hydrocortisone hormone in suspension and monolayer cultures by unknown
Control of Rat C6 Glioma Cell Proliferation: 
Uncoupling of the Inhibitory Effects of Hydrocortisone 
Hormone in Suspension and Monolayer Cultures 
MARl  C.  S.  ARMELIN,  RITA  C.  STOCCO, and HUGO  A.  ARMELIN 
Instituto de Quimica,  Universidade de SSo Paulo, C. P. 20780, SSo Paulo, 05508 Brasil 
ABSTRACT  We undertook a comparative  study of the effects of the hormone hydrocortisone 
(Hy)  on  C6 glioma  cells  grown  in  monolayer  and  in  suspension  in  cultures.  We  found  Hy 
reversibly  renders C6 cells anchorage- and serum-dependent for their growth.  In  monolayer 
cultures,  Hy  was found  to  inhibit  cell  cycle  traversing  exclusively  at  G1  phase.  In  agarose 
suspension, Hy was found to block colony development.  Hy-resistant variants were selected 
and isolated in agarose suspension. Examination  of these variants showed that cells selected 
for Hy-resistance in suspension can be Hy sensitive when anchored to a solid substrate. We 
conclude that resistance to Hy in suspension and resistance to it in monolayer culture are two 
independent phenotypes. 
Cell transformation is characterized by loss of anchorage and 
serum dependence for growth (l, 2). The relationship between 
anchorage  and  serum  dependence  is  still  obscure.  Serum 
dependence reflects the cells'  growth requirements for hor- 
mones and growth factors (3,  4,  5).  One interpretation for 
anchorage dependence assumes no qualitative difference be- 
tween anchored cells and cells in suspension as far as the types 
of serum  factors required; only greater amounts would  be 
required by cells in suspension (6). Another interpretation is 
that  cell-substrate and  ceil-cell  interactions modulate  non- 
transformed cells' response to growth factors and hormones 
that regulate their proliferation (7). Only a better understand- 
ing of the actions of hormones and growth factors in both 
suspension and monolayer cultures will allow the elucidation 
of this important problem. 
The growth of C6 rat glioma cells (8) is inhibited by gluco- 
corticoids (9)  and  stimulated  by  pituitary  peptide  growth 
factors (10,  11,  12). Results described here show that hydro- 
cortisone (Hy), a glucocorticoid hormone, reversibly renders 
C6 cells anchorage- and serum-dependent for their growth. 
Variant  clones selected for resistance to  Hy in  suspension 
cultures were not resistant when anchored to a solid substrate. 
The data point to differences between hormonal action  in 
suspension and that in monolayer cultures. 
MATERIALS  AND  METHODS 
Cell Culture:  Stock cultures were regularly kept in 5% fetal calf serum 
(FCS)-95%  Dulbecco's  modified  Eagle's medium (DME)  as  previously  de- 
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scribed (13). The strain of rat C6 glial cells (8) used here came originally from 
the American Type Culture Collection (CLL 107, Rockville, MD). Variant ST I 
was isolated in this laboratory (14) by subjecting cultures to serum-free medium 
and collecting cells that rounded up as previously described (15). 
Hormones and Growth Factors:  Hydrocortisonewas from Sigma 
Chemical Co. (St. Louis, MO). Pituitary growth factor was prepared by Dr. A. 
G. Gambarini,  in our laboratory,  according to procedures  described in refer- 
ences 13,  16, and 17. The preparation  used in this work consisted of the CM-1 
fraction (16, 17) that contains  several protein  bands and both acid and basic 
active growth factors. 
Determination  of Labeling Index and Mitotic Index:  Cells 
were seeded at 2 x  104 cells/era 2 onto glass coverslips in 5% FCS-DME. For 
MI determination,  cells were fixed with 10% trichloroacetic acid (TCA) stained 
with Giemsa  and examined  under light microscope; at least  10  microscopic 
fields and  2,000 cells were  counted  per coverslip.  For labeling  index  (LI) 
determinations,  at  each  time  point  cells were  pulse-labeled  (30  min)  with 
methyl-[3H]thymidine ( 1 gCi/ml; 50 Ci/mmol). Coverslips were extracted twice 
with 10% TCA, washed with 95% ethanol,  air dried, and covered with Kodak 
AR-10 stripping film. Percent  of labeled nuclei was estimated  by counting  a 
minimum of 10 microscopic fields and at least 1,000 cells per coverslip. 
Growth  in  Agarose Suspension:  Cells  were plated at different 
densities  in  35-ram  dishes containing  a  layer of 0.6%  agarose,  10%  FCS- 
medium.  Plating  medium consisted of 0.3%  agarose and  10%  FCS. Liquid 
10% FCg-medium  (1  ml/dish)  was added 24 h after plating and renewed, by 
gentle aspiration, every 2 to 4 d. Plating efficiency was determined  at 21 d by 
counting  macroscopic (l-3-mm diameter)  colonies. In the presence of Hy, in 
additiontothemacroscopiccolonies,weeventuallydetectedabackgroundofmicro- 
colonies  that  could  be  scored  only  under a  stereo-microscope.  Since these 
microcolonies  failed to develop  into macrocolonies  when  longer cultivation 
periods were allowed (up to 40 d), they were not scored in plating efficiency 
assays. 
The effects of hormones and growth factors on growth in suspension were 
assessed by addition to the liquid overlay medium. Pituitary fraction (5 ug/ml) 
was added every 2-3 d and Hy (250 ng/ml) every time the liquid overlay was 
renewed. 
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pension:  For purposes of variant selection and of estimating the rates at 
which Hy-resistant variants arise, cell densities no higher than  104 cells per 
plate were used. Colonies  grown  in the presence  of Hy for 21 d were individually 
picked with a  Pasteur pipet. We gently washed each colony to  eliminate 
surrounding  agarose by pipeting in liquid medium. The colony was transferred 
to a test tube containing fresh liquid medium, and the cells  were dissociated  by 
vigorous pipeting and plated at low cell density for recloning  in solid substrate. 
The rate at which Hy-resistant clones arise in Ca cultures was estimated by 
taking freshly isolated, sensitive  clones, plating them in Hy-containing  agarose 
suspension  (104 cells per 35-mm dish), and counting the macroscopic colonies 
that developed. 
Characterization  of Variants:  All variants were analyzed by kary- 
otyping and by the presence of functional B-receptors. Karyotype analysis 
included G and C banding according to references 18 and 19. Chromosome 
identification and counts were carried out in enlarged pictures taken at 400 
magnification  under a Zeiss photomicroscope, by comparison with the Com- 
mittee Standard Karyotype for Rattus  norvergicus  (20). Our strain (39-44 
chromosomes per cell; modal number 42) is characterized by the presence of 
marker chromosome t (6q, 8q) which is likely  to have arisen by a Robertsonian 
translocation between chromosomes 6 and 8. Among the clones isolated, the 
number of chromosomes per cell ranges from 36 to 44 with modal number 
from 40 to 42. All clones display that t (6q, 8q) marker, usually in monosomy. 
We have not found specific cytogenetic  markers among the variants isolated. 
C6 and all variant lines that originated  from it presented  a few small acrocentric 
chromosomes that  lack specific banding patterns. Functional B-adrenergic 
receptors, an important physiological  marker of the Ca parental line (21, 22), 
were assayed in the variants by scoring,  under phase-contrast microscope,  the 
cell shape change caused in glial cells by cAMP (10  -5, 10  -4, and 10  -3 M) and 
catecholamines (10  -7,  10  -6, and  10  -5 M). Clones P2, Ps, PT, PH, and STI 
responded to isoproterenol, noradrenaline, and cAMP, STI being the most 
responsive  clone. 
RESULTS 
Hy Inhibits Growth of Gliorna Cells Both in 
Agarose Suspension and in Monolayer Cultures 
C6 glioma cells grow in agarose  suspension cultures (80% 
plating efficiency [PE] at 2  x  102 cells per dish). This colony 
growth is reversibly blocked by Hy (zero PE at 2  x  102 cells 
per dish; see Table I). Growth can be resumed by the addition 
of a pituitary growth factor preparation (20% PE) or hormone 
withdrawal (80% PE). 
Hy also inhibits growth of C6 cells in monolayer cultures. 
This growth inhibition is manifested by reduction in both the 
growth rate and the saturation density (Table II). The overall 
result of Hy action on the growth control pattern of C6 cells 
is  to  reversibly  restore  anchorage  and  serum  and  density 
dependence. 
Hy Effect Maps at G1 Phase of the Cell Cycle 
In monolayer, the effect of Hy could be traced to a reduc- 
tion in the  cell  cycle traverse  rate  exclusively at  G~  phase. 
TABLE  I 
Growth in Agarose Suspension of Hydrocortisone-resistant and 
Hydrocortisone-sensitive Variants of C6 Glioma Cells: Effect of 
Hydrocortisone 
Plating efficiency (%) 
No. of experi- 
Cell type  -Hy  +Hy  ments 
C6 (parental)  60 +  20  0  6 
P2  75 +  5  30 +  4  2 
P5  20 +  3  20 +  2  2 
P7  75 _  5  75 +  6  2 
P.  46 --- 3  43 -  4  2 
ST1  70 +  10  0  4 
2 x  102 cells were plated per 35-mm dish following the protocol detailed in 
Methods. Values (SEM)  are averages of the indicated number of experiments. 
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TABLE  tl 
Growth in Monolayer of Hydrocortisone-resistant and 
Hydrocortisone-sensitive Variants of C6 Glioma Cells: Effect of 
Hydrocortisone 
Saturation density 
Doubling time (h)  (cells/cm 2 x  105) 
Cell type  -Hy  +Hy  -Hy  +Hy 
C6 (parental)  14  32  5.2  1.2 
P2  17  34  2.6  0.8 
P5  16  16  5.0  5.0 
Pz  14  14  4.7  3.6 
Pu  17  28  3.0  0.6 
ST1  14  27  4.5  1.0 
105 cells were plated  per 35-mm dish (5% FCS medium)  in the absence or 
presence of hydrocortisone (250 ng/ml).  Cells were allowed to grow until 
saturation density was reached, counting two plates every 24 h. Saturation 
densities and  doubling times were estimated  graphically  from the growth 
curves. The values are averages of two independent experiments, performed 
with the same batch of medium  and serum, in which deviations  in results 
were no greater than 10%. 





FIGURE  1  Effect of hydrocortisone 
treatment on ST1 cells' growth rate: 
5 x  103 cells/cm 2 were seeded onto 
glass  coverslips in  15-cm  diameter 
petri dishes and  5%  FCS  medium. 
When  exponential  growth  was 
reached,  hydrocortisone (250  ng/ 
ml) was added and coverslips were 
withdrawn  periodically,  fixed, and 
stained  with  Giemsa's.  10  micro- 
scopic fields were counted per cov- 
erslip  (two  coverslips/point).  O, 
control,  no addition. @,  hydrocor- 
tisone addition. 
Addition  of  Hy  to  exponentially growing  cells  leads  to  a 
biphasic growth curve (Fig.  1).  14-15 h  after hormone addi- 
tion,  the  doubling  time  increases  from  15  to  24  h.  This 
hormonal effect could be explained by an inhibition of cells' 
progress through the G~ phase of the cell cycle. Data support- 
ing this proposition were obtained in kinetic studies following 
Hy addition to C6 cells (ST1  variant) exponentially growing 
in high (5%) serum medium. LI and mitotic index (MI) are 
shown in Figs.  2  and  3,  respectively.  LI  remained constant 
for the first 4.5 to 5.0 h of hormone treatment (Fig. 2), whereas 
MI took longer to drop, i.e., 14-15 h. Therefore, the two gates 
of the  cell  cycle,  namely,  entry  into  S  phase  and  mitosis, 
detected reduction in cell cycle progress and in a  sequential 
manner (first, a decrease in S phase entry and, ~  10 h later, a 
diminution in mitosis frequency). 
When  the  medium  of  exponentially  growing  cells  was 
changed to low (0.2%) serum medium plus Hy, the LI also 
remained constant for 4.5  to  5.0  h  (Fig. 2).  However,  after 
this initial constant period, LI dropped continuously, reaching 
negligible levels 12 h  after reduction of serum concentration 
and hormone addition. Reduction of serum concentration to 
0.2%,  per  se,  also  reduces  LI  but relatively high  levels are 
maintained (19% after 24 h). These results indicated that the 
glucocorticoid hormone completely halts the cell entry into S 
phase in medium containing low serum levels. 
Altogether, these data are consistent with the glucocorticoid 
hormone's  acting  by  exclusively  inhibiting cells'  progress 
through  G,  phase.  The exact time point, before S  phase,  at 20 
4  8  ~2  C6 
Hours After 
Hydrocort/sone  Add///on 
FIGURE 2  Effect of hydrocortisone 
on the LI of exponentially growing 
ST1 cells:  Cells  plated as in Fig. 1. 
Hydrocortisone  (250  ng/ml)  was 
added  at  zero  time,  and  30-min 
pulses of [3H]thymidine  (1 /~Ci/ml; 
50 Ci/mmol)  were carried out pe- 
riodically  thereafter.  LI was  deter- 
mined  as  described  in  Materials 
and Methods. The graph  is a com- 
posite  of  3  independent  experi- 
ments. F-I, control, no additions. O, 
hydrocortisone  addition.  O,  me- 
dium  changed to 0.25%  FCS me- 
dium plus hydrocortisone. 
which cells are affected by the hormone cannot be determined 
from these results because it should be equal to 4.5  h  (time 
interval  with  constant  LI  in  Fig.  2)  minus  the  unknown 
latency period for hydrocortisone effective action. 
Agarose Suspension Cultures Used to Isolate Hy- 
resistant C6 Variants 
We  reasoned  that  agarose suspension  cultures  would  be 
useful for selection of C6 variants capable of escaping the Hy 
growth block. The selection of Hy-resistant variants was based 
on always taking the largest colonies from suspension cultures 
kept in the presence of Hy (see Materials and Methods). 
Several colonies were isolated by a single selection step in 
250 ng/ml Hy. Clones P2, Ps, P7, and P]~  proved to be Hy- 
resistant variants, as indicated by the plating efficiency results 
of Table I. Thus in  a  single selection  step it is possible to 
obtain stable Hy-resistant variants from the C6 line. 
Cells resistant to Hy for growth in suspension arose spon- 
taneously from freshly cloned C~ cultures at an estimated rate 
of one variant in 104 cells per generation. Different from other 
Hy-sensitive C6  sublines,  clone  ST1  has  not  yielded  Hy- 
resistant cells even after many generations in culture. 
Some Hy-resistant Variants, Selected in Agarose 
Suspension, Are Sensitive to Hy in 
Monolayer Cultures 
The hormonal growth response of variants selected in sus- 
pension cultures was analyzed in cells attached to solid sub- 
strate. The unanticipated outcome was that cells selected for 
Hy-resistance  in  suspension  cultures  were  not  necessarily 
resistant when anchored to a solid substrate. Table II presents 
the  results of doubling time and  saturation  density for the 
variants selected in suspension. Clones P5 and P7 proved to 
be also Hy-resistant in monolayer cultures. On the other hand, 
clones P2 and Pj~ which are Hy-resistants in suspension be- 
haved like the parental C6 or the highly sensitive clone STI. 
DISCUSSION 
Hy has been known to inhibit growth of rat C6 glioma cells 
(9).  More than growth inhibition,  Hy reversibly renders C6 
cells anchorage (Table I) and serum and density dependent 
for growth (Table I1 and Fig. 2). These effects are observed at 
physiological concentrations (maximal activity at 50 ng/ml). 
Identical results are obtained with the synthetic glucocorticoid 
hormone,  dexamethasone  (maximal  activity  at  20  ng/ml). 
Progesterone is poorly effective whereas sex steroids (estradiol 
and testosterone) are totally ineffective (23,  24; Armelin, M. 
C. S. and H. A. Armelin, unpublished results).  Therefore the 
effects reported seem to be specific for glucocorticoid hor- 
mones. 
Kinetic studies (Fig.  1-3) have shown that in  monolayer 
cultures Hy reduces C6 cells' proliferation by inhibiting cell 
cycle progress exclusively at the Gj phase. This is consistent 
with our previous observation that Hy increases the lag before 
DNA  synthesis  initiation  (G~  phase)  in  STI  cells  growth 
arrested by serum starvation and restimulated by serum read- 
dition to the medium (14). 
Others have reported glucocorticoids to increase the levels 
of cAMP in C6 glioma cells (25). The effects we report for Hy 
were not accompanied by changes in the steady state levels of 
cAMP. We measured the intracellular cAMP levels of expo- 
nentially growing STI  cells  and  obtained 9.5  (_+ 0.5  SEM) 
pmol/mg protein; 24 h  of Hy treatment did  not alter these 
levels. Furthermore, 24 h after reducing the serum concentra- 
tion  to 0.2%,  cAMP levels increased to  20.5  (-+  0.6  SEM) 
pmol/mg protein, irrespective to the presence or absence of 
Hy (M. C. S. Armelin and H. Armelin, unpublished results). 
Analysis of the growth properties presented by the variant 
clones demonstrated that Hy resistance in suspension is not 
coupled to Hy resistance in solid substrate.  Thus, clones P2 
and  PI~, selected  for Hy-resistance in  suspension  (Table  I) 
were in  fact sensitive to this hormone when anchored to a 
solid substrate (Table II). This does not prove that Hy acts by 
two completely independent mechanisms in suspension cul- 
tures and attached cells. But it suggests that, ifa single central 
system coordinates Hy action, branching into different routes 
must occur at some point in  order to  account for the two 
independent phenotypes found. 
In several instances the transformed state of a  given cell 
line has been shown to be related to the constitutive produc- 
tion of  a tumor growth factor by the cells (26). It is conceivable 
that Hy could be inhibiting the constitutive production of an 
autostimulatory tumor growth factor. This possibility seems 
rather unlikely for the  following reason:  at the time of Hy 
addition,  exponentially  growing  cultures  (as  in  Figs.  1-3) 
would have accumulated tumor factor in their medium and 
should not have been growth inhibited by Hy. Instead, ceils 
were readily responsive to its inhibitory action as shown in 
the LI experiment in Fig. 2. 
We are inclined to believe that Hy acts in C6 cells, changing 
their transformed phenotype, by a more direct effect. It can 
be speculated that Hy may turn off an oncogene or modulate 
its expression. The accompanying paper describes alterations 
caused by Hy in C6 cells which  might be related to growth 
control  mechanisms.  Fibronectin  deposition  on  the  cells' 
surface and  modifications in  cytoskeleton functioning  and 
architecture are among the effects described.  Elsewhere, we 
also show that Hy reversibly renders C6 cells growth dependent 
on high external Ca  2* concentrations (24). 
~  6Jal°=  ~  ~o  FIGURE  3  Effect  ot  nydrocorti- 
iI  i  k5  o'-  sone  on the MI  of exponentially 
growing  ST1  cells:  Cells  plated 
-~  and treated as in  Fig.  1.  MI  was 
•  =  determined  as described  in  Ma- 
terials  and  Methods.  O,  control, 
0  10  ~0  no  additions.  I,  hydrocortisone 
Hours  After  addition. 
Hydrocor//sone Addilion 
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